Chinook Therapeutics is a clinical-stage immunotherapy company that discovers, develops and commercializes medicines for rare, severe chronic kidney diseases, utilizing advanced technologies such as RNA sequencing and human-derived organoids
Chinook Therapeutics is a clinical-stage immunotherapy company that discovers, develops and commercializes medicines for rare, severe chronic kidney diseases, utilizing advanced technologies such as RNA sequencing and human-derived organoids.
The top three firms on F4's Biotech & Life Sciences investor list.